Here's more of that context that paints a better picture. > First, it’s important to note that Enzymit’s use of cloud computing mainly entailed computationally

Here's more of that context that paints a better picture. > First, it’s important to note that Enzymit’s use of cloud computing mainly entailed computationally intensive calculations for protein design. We do not have (yet) any public-facing applications that need to scale across multiple geographical zones and handle millions of requests per minute. Our primary use case is running CPU and GPU heavy analyses, and for that use case, we have found the IaaS/public cloud solution to be far from cost-effective in the long term.